Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Enzo Biochem Inc's Business Segments
Enzo Biochem Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 9
Regions Reported
2
Enzo Biochem Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Region - FY
- Europe26.6%
- Asia Pacific10%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Europe | $ 2 | 26.6% |
| Asia Pacific | $ 1 | 10% |
Description of Enzo Biochem Inc
Enzo Biochem Inc. is a global biotechnology company that specializes in the development and commercialization of innovative life science research tools, clinical diagnostic products, and therapeutic offerings. The company has been involved in the field of biomedical research for over 40 years and has established itself as a leading player in the industry.
The company operates through three main units: Enzo Life Sciences, Enzo Clinical Labs, and Enzo Therapeutics. Enzo Life Sciences is dedicated to developing and providing a wide range of high-quality research reagents, assay kits, and platforms to enable scientists to better understand diseases and develop new treatments. The company's product portfolio includes more than 40,000 high-performance antibodies, proteins, peptides, and small molecules that are used in numerous research areas, including cancer, cardiovascular disease, neurodegeneration, infectious diseases, and genomics.
Enzo Clinical Labs is a full-service clinical laboratory that provides an array of advanced diagnostic testing services to physicians, patients, and hospitals across the U.S. The company specializes in testing for gastrointestinal, endocrine, and infectious diseases, as well as cancer, genetic disorders, and drug monitoring. Enzo Clinical Labs has received numerous accreditations and certifications from leading organizations, including the College of American Pathologists (CAP), CLIA, and the New York State Department of Health.
Enzo Therapeutics is focused on developing innovative therapeutic products for the treatment of cancer, autoimmune, and inflammatory disorders. The company has a pipeline of novel small molecules and biologics that target specific disease pathways and have the potential to provide more effective therapies with fewer side effects than traditional treatments.
Enzo Biochem has a strong intellectual property portfolio, with over 270 issued patents worldwide covering a wide range of technologies, including nucleic acid labeling, detection, and quantification, recombinant protein production, and monoclonal antibody-based products. The company has also formed strategic partnerships with leading academic and commercial organizations to develop new products and technologies.
Enzo Biochem has a diverse customer base ranging from academic researchers to biotech and pharmaceutical companies, clinical laboratories, and healthcare providers. The company has a global presence with operations in the U.S., Europe, and Asia and sells its products and services in more than 100 countries worldwide.
The company has a strong financial position, with revenues of $101 million in fiscal year 2020 and a net income of $2 million. The company has a market capitalization of approximately $118 million and is traded on the New York Stock Exchange under the ticker symbol ENZ.
In summary, Enzo Biochem Inc is a well-established and respected biotech company that is focused on developing and commercializing innovative life science research tools, clinical diagnostic products, and therapeutic offerings. With a strong product pipeline, intellectual property portfolio, and global presence, the company is well-positioned to continue to grow and succeed in the dynamic and competitive biotech industry.
The company operates through three main units: Enzo Life Sciences, Enzo Clinical Labs, and Enzo Therapeutics. Enzo Life Sciences is dedicated to developing and providing a wide range of high-quality research reagents, assay kits, and platforms to enable scientists to better understand diseases and develop new treatments. The company's product portfolio includes more than 40,000 high-performance antibodies, proteins, peptides, and small molecules that are used in numerous research areas, including cancer, cardiovascular disease, neurodegeneration, infectious diseases, and genomics.
Enzo Clinical Labs is a full-service clinical laboratory that provides an array of advanced diagnostic testing services to physicians, patients, and hospitals across the U.S. The company specializes in testing for gastrointestinal, endocrine, and infectious diseases, as well as cancer, genetic disorders, and drug monitoring. Enzo Clinical Labs has received numerous accreditations and certifications from leading organizations, including the College of American Pathologists (CAP), CLIA, and the New York State Department of Health.
Enzo Therapeutics is focused on developing innovative therapeutic products for the treatment of cancer, autoimmune, and inflammatory disorders. The company has a pipeline of novel small molecules and biologics that target specific disease pathways and have the potential to provide more effective therapies with fewer side effects than traditional treatments.
Enzo Biochem has a strong intellectual property portfolio, with over 270 issued patents worldwide covering a wide range of technologies, including nucleic acid labeling, detection, and quantification, recombinant protein production, and monoclonal antibody-based products. The company has also formed strategic partnerships with leading academic and commercial organizations to develop new products and technologies.
Enzo Biochem has a diverse customer base ranging from academic researchers to biotech and pharmaceutical companies, clinical laboratories, and healthcare providers. The company has a global presence with operations in the U.S., Europe, and Asia and sells its products and services in more than 100 countries worldwide.
The company has a strong financial position, with revenues of $101 million in fiscal year 2020 and a net income of $2 million. The company has a market capitalization of approximately $118 million and is traded on the New York Stock Exchange under the ticker symbol ENZ.
In summary, Enzo Biochem Inc is a well-established and respected biotech company that is focused on developing and commercializing innovative life science research tools, clinical diagnostic products, and therapeutic offerings. With a strong product pipeline, intellectual property portfolio, and global presence, the company is well-positioned to continue to grow and succeed in the dynamic and competitive biotech industry.
Enzo Biochem Inc. is recognized as a prominent life sciences and diagnostics company, offering a comprehensive suite of segments, products, and services tailored for clinical diagnostics and research. The company is committed to advancing the fields of molecular diagnostics and life sciences with innovative solutions that support healthcare professionals and researchers alike.
Segments:
1. Life Sciences
- Enzo Biochem’s life sciences segment is vital for laboratories focused on accelerating research and discovery. This segment provides essential tools that facilitate scientific inquiry, including:
- Nucleic Acid Detection Kits: These kits are designed to efficiently detect and quantify DNA and RNA, crucial for various genetic analyses.
- Immunoassays: A variety of assay formats, including ELISA and Western blotting, are available to measure specific proteins and biomarkers in biological samples.
- Antibodies: The company supplies numerous antibodies utilized in research and diagnostic settings, further enhancing the capabilities of life sciences laboratories.
2. Clinical Diagnostics
- The clinical diagnostics segment plays a critical role in healthcare by providing sophisticated diagnostic solutions. This segment serves as an essential resource for diagnosing and monitoring a wide array of conditions:
- Infectious Diseases: Enzo provides diagnostic tools for identifying pathogens, enabling timely treatment interventions.
- Cancers: Solutions include tests for tumor markers and genetic alterations that are pivotal for cancer detection and management.
- Autoimmune Disorders: Specialized assays are available to assist in the detection and monitoring of autoimmune conditions, facilitating better patient outcomes.
- Molecular Diagnostics: This area enables sensitive detection of genetic material, essential for diagnosing various diseases at the molecular level.
- Cytogenetics: Enzo supports studies involving chromosome analysis, which is vital for cancer and genetic disorder diagnostics.
Products:
1. Molecular Diagnostics
- Enzo Biochems product line in molecular diagnostics includes:
- RNA and DNA Extraction Kits: Optimized for efficient isolation of nucleic acids from a variety of sample types.
- PCR and qPCR Reagents: High-quality reagents that ensure accurate amplification and quantification of nucleic acids, critical for numerous applications in both research and clinical settings.
- Hybridization Probes: These products enhance the specificity of nucleic acid detection methods, making them indispensable in molecular diagnostics.
2. Immunoassays
- The company offers several types of immunoassays that feature:
- ELISA Kits: Used for quantitative detection of proteins and biomarkers, crucial for clinical diagnostics and research applications.
- Western Blotting Kits: These kits are essential for confirming the presence of specific proteins within a sample.
- Flow Cytometry Reagents: Solutions designed for cell-based assays, allowing for detailed analysis of cell populations based on specific markers.
3. Antibodies
- Enzo Biochems extensive antibody portfolio includes:
- Polyclonal Antibodies: Derived from multiple cell types, these antibodies provide a broad recognition of antigens.
- Monoclonal Antibodies: These are highly specific antibodies produced from a single clone of cells, ideal for targeted research and diagnostic applications.
- Recombinant Antibodies: Engineered antibodies that offer consistent and reliable performance across varied experimental conditions.
Services:
1. Custom Assay Development
- Enzo Biochem specializes in developing custom assays tailored to meet the specific needs of researchers and clinical applications. This service includes:
- Consultation and Design: Collaborating with clients to identify their needs and develop assays that deliver targeted results.
- Optimization and Validation: Ensuring that custom assays are performed accurately and repeatably.
2. Molecular Diagnostic Services
- This service segment provides comprehensive molecular diagnostic offerings, including:
- Laboratory-Developed Tests (LDTs): Custom tests developed in-house to address specific diagnostic challenges.
- Cytogenetic Analysis: Detailed examination of chromosomes to identify genetic abnormalities.
- Next-Generation Sequencing (NGS): Facilitating in-depth genetic analysis, enabling researchers to uncover critical insights into genomic data.
3. Clinical Trial Support
- Enzo Biochem supports clinical trials with services designed to streamline processes and enhance outcomes, including:
- Sample Management: Efficient handling, tracking, and processing of samples collected during trials.
- Genetic Analysis: Offering comprehensive analyses to support the clinical endpoints of trials.
- Data Analysis and Validation Testing: Critical for ensuring the integrity and reliability of trial data, facilitating robust conclusions based on the research outcomes.
Through these segments, products, and services, Enzo Biochem Inc. demonstrates its commitment to empowering research and improving clinical diagnostics, ultimately contributing to advancements in healthcare and life sciences.
Segments:
1. Life Sciences
- Enzo Biochem’s life sciences segment is vital for laboratories focused on accelerating research and discovery. This segment provides essential tools that facilitate scientific inquiry, including:
- Nucleic Acid Detection Kits: These kits are designed to efficiently detect and quantify DNA and RNA, crucial for various genetic analyses.
- Immunoassays: A variety of assay formats, including ELISA and Western blotting, are available to measure specific proteins and biomarkers in biological samples.
- Antibodies: The company supplies numerous antibodies utilized in research and diagnostic settings, further enhancing the capabilities of life sciences laboratories.
2. Clinical Diagnostics
- The clinical diagnostics segment plays a critical role in healthcare by providing sophisticated diagnostic solutions. This segment serves as an essential resource for diagnosing and monitoring a wide array of conditions:
- Infectious Diseases: Enzo provides diagnostic tools for identifying pathogens, enabling timely treatment interventions.
- Cancers: Solutions include tests for tumor markers and genetic alterations that are pivotal for cancer detection and management.
- Autoimmune Disorders: Specialized assays are available to assist in the detection and monitoring of autoimmune conditions, facilitating better patient outcomes.
- Molecular Diagnostics: This area enables sensitive detection of genetic material, essential for diagnosing various diseases at the molecular level.
- Cytogenetics: Enzo supports studies involving chromosome analysis, which is vital for cancer and genetic disorder diagnostics.
Products:
1. Molecular Diagnostics
- Enzo Biochems product line in molecular diagnostics includes:
- RNA and DNA Extraction Kits: Optimized for efficient isolation of nucleic acids from a variety of sample types.
- PCR and qPCR Reagents: High-quality reagents that ensure accurate amplification and quantification of nucleic acids, critical for numerous applications in both research and clinical settings.
- Hybridization Probes: These products enhance the specificity of nucleic acid detection methods, making them indispensable in molecular diagnostics.
2. Immunoassays
- The company offers several types of immunoassays that feature:
- ELISA Kits: Used for quantitative detection of proteins and biomarkers, crucial for clinical diagnostics and research applications.
- Western Blotting Kits: These kits are essential for confirming the presence of specific proteins within a sample.
- Flow Cytometry Reagents: Solutions designed for cell-based assays, allowing for detailed analysis of cell populations based on specific markers.
3. Antibodies
- Enzo Biochems extensive antibody portfolio includes:
- Polyclonal Antibodies: Derived from multiple cell types, these antibodies provide a broad recognition of antigens.
- Monoclonal Antibodies: These are highly specific antibodies produced from a single clone of cells, ideal for targeted research and diagnostic applications.
- Recombinant Antibodies: Engineered antibodies that offer consistent and reliable performance across varied experimental conditions.
Services:
1. Custom Assay Development
- Enzo Biochem specializes in developing custom assays tailored to meet the specific needs of researchers and clinical applications. This service includes:
- Consultation and Design: Collaborating with clients to identify their needs and develop assays that deliver targeted results.
- Optimization and Validation: Ensuring that custom assays are performed accurately and repeatably.
2. Molecular Diagnostic Services
- This service segment provides comprehensive molecular diagnostic offerings, including:
- Laboratory-Developed Tests (LDTs): Custom tests developed in-house to address specific diagnostic challenges.
- Cytogenetic Analysis: Detailed examination of chromosomes to identify genetic abnormalities.
- Next-Generation Sequencing (NGS): Facilitating in-depth genetic analysis, enabling researchers to uncover critical insights into genomic data.
3. Clinical Trial Support
- Enzo Biochem supports clinical trials with services designed to streamline processes and enhance outcomes, including:
- Sample Management: Efficient handling, tracking, and processing of samples collected during trials.
- Genetic Analysis: Offering comprehensive analyses to support the clinical endpoints of trials.
- Data Analysis and Validation Testing: Critical for ensuring the integrity and reliability of trial data, facilitating robust conclusions based on the research outcomes.
Through these segments, products, and services, Enzo Biochem Inc. demonstrates its commitment to empowering research and improving clinical diagnostics, ultimately contributing to advancements in healthcare and life sciences.